Orion Health reinforces security credentials with HITRUST and DirectTrust accreditations
HITRUST Risk-based, 2-year Certification for Amadeus validates commitment to protecting sensitive information, while Communicate product also achieves DirectTrust™ HISP Accreditation AUCKLAND, New Zealand, Feb. 8, 2023 /PRNewswire/ -- Orion Health, a global leader in population health software, today announced that it has gained leading security credentials for two of its flagship products....
Complete Genomics Drops Genome Sequencing Price to Sub $100 at AGBT General Meeting
DNBSEQ-T20×2*produces up to 50,000 WGS per year at a first sub hundred-dollar price per genome DNBSEQ-T7* offers an outstanding $1.5/Gb price for sequencing consumablesDNBSEQ-G99* delivers a first-in-class PE150 run within 12 hours with a data output of 8- 48 Gb per runstLFR library prep kit enables more complete and accurate haplotype-phased genomes HOLLYWOOD, Fla., Feb. 7, 2023 /PRNewswire/ --...
Mount Elizabeth Hospital first in Southeast Asia to acquire Naeotom Alpha from Siemens Healthineers
Naeotom Alpha is world's first CT scanner with photon-counting technology. Mount Elizabeth Hospital (MEH) will be the first hospital in Southeast Asia to offer patients benefits of photon-counting technology. SINGAPORE, Feb. 7, 2023 /PRNewswire/ -- Mount Elizabeth Hospital will be the first hospital in Southeast Asia to acquire...
RNAimmune mRNA Cancer Vaccine Program Accepted for Oral Presentation at the 2023 AACR Annual Meeting
HONG KONG, GERMANTOWN, Md., and SUZHOU, China, Feb. 7, 2023 /PRNewswire/ -- Sirnaomics Ltd. (the "Company", Stock Code: 2257.HK, and together with its subsidiaries, the "Group" or "Sirnaomics"), a leading biopharmaceutical company in discovery and development of RNAi therapeutics today announced that the Company's subsidiary, RNAimmune, Inc. ("RNAimmune"), has been accepted for oral presentation at the American Association for Cancer...
J INTS BIO, Oral TKI ‘JIN-A04’, poster presentation of HER2 exon20 insertion mutation in NSCLC
SEOUL, South Korea, Feb. 7, 2023 /PRNewswire/ -- J INTS BIO announced that the preclinical results of "JIN-A04," a novel oral tyrosine kinase inhibitor (TKI) targeting HER2 Exon20 insertion mutation in NSCLC, will be presented at the upcoming 2023 American Cancer Research Association meeting in Orlando, U.S. from April 14 to 19. J INTS BIO CI HER2 Exon20...
Thermo Fisher Scientific launches Cell Therapy Collaboration Center Program in Singapore to accelerate therapy development across Asia Pacific
Program supports cell therapy innovators in the development of next-generation, life-saving drugs and therapeutics through every stage of their journey to improve patient outcomes SINGAPORE, Feb. 7, 2023 /PRNewswire/ -- Thermo Fisher Scientific Inc., the world leader in serving science, today announced the launch of its new Cell Therapy Collaboration Center Program in Singapore to accelerate cell therapy development...
INAUGURAL LAZADA RUN TO ADD FITNESS TO LIFE ACROSS SOUTHEAST ASIA
SINGAPORE, Feb. 7, 2023 /PRNewswire/ -- Southeast Asia's pioneer eCommerce platform, Lazada, today announced its inaugural running event across the region. The first ever running event organized by an eCommerce platform in Southeast Asia, the Lazada Run will flag off in Ho Chi Minh, Vietnam, before making its way to Indonesia, Thailand,...
SHAMIR OPTICS SELECTS INUITIVE’S NU4000 TO POWER ITS NEXT-GENERATION DIGITAL MEASUREMENT DEVICE
Spark™ 4, Shamir's newest ultra-precise digital measurement device, deploys Inuitive's NU4000 vision-on-chip processor together with IMDT's accurate 3D technology, to offer opticians a simple and effective ophthalmic measurement experience RA'ANANA, Israel, Feb. 7, 2023 /PRNewswire/ -- Shamir Optical Industry Ltd., a world-leading designer and producer of premium progressive lenses and molds for...
Suvoda Introduces Extensible Software Platform Bringing Proven Tech Innovation to Clinical Trial Management
Platform reduces friction across the eConsent, IRT, and eCOA user experience for sponsors, CROs, sites and patients. PHILADELPHIA, Feb. 7, 2023 /PRNewswire/ -- Suvoda LLC, a global clinical trial technology company that specializes in complex studies in therapeutic areas like oncology, central nervous system (CNS), and rare disease, today unveiled a purpose-built...
Tavneos® (avacopan) approved in Australia for the treatment of ANCA-associated vasculitis
First targeted therapy available for the treatment of two main types of ANCA-associated vasculitis (AAV), a rare and systemic disease MELBOURNE, Australia, Feb. 7, 2023 /PRNewswire/ -- Vifor Fresenius Medical Care Renal Pharma (VFMCRP) today announced the Therapeutic Goods Administration (TGA) in Australia has approved Tavneos® in combination with a rituximab or...
